[new weapons!] brawl 2 vs [] InVision's: Web-Verse [V3]
[new weapons!] brawl 2 currently leads with 779 concurrent players against 698. On all-time peak the record belongs to [] InVision's: Web-Verse [V3] at 959 concurrent players, versus 862. Lifetime, [new weapons!] brawl 2 has more visits (199.2M vs 117.7M). Full side-by-side history for [new weapons!] brawl 2 and [] InVision's: Web-Verse [V3] is charted above.
[new weapons!] brawl 2
779
playing now
848 24h peak Β· 199.2M visits
VS
[π·οΈ] InVision's: Web-Verse [V3]
698
playing now
959 24h peak Β· 117.7M visits
Player count history
[new weapons!] brawl 2[] InVision's: Web-Verse [V3]
Head to head
| Metric | [new weapons!] brawl 2 | [] InVision's: Web-Verse [V3] | Difference |
|---|---|---|---|
| Playing now | 779 | 698 | 81 |
| 24h peak | 848 | 959 | 111 |
| 24h average | 545 | 720 | 175 |
| 7-day peak | 862 | 959 | 97 |
| 7-day average | 555 | 595 | 40 |
| 30-day peak | 862 | 959 | 97 |
| All-time peak | 862 | 959 | 97 |
| 24h change | β² 12.4% | β² 53.5% | β |
| 7d change | β | β | β |
| Total visits | 199.2M | 117.7M | 81.5M (1.7Γ) |
| Visits (24h) | 69.9K | 130.7K | 60.8K (1.9Γ) |
| Visits (7d) | 191.1K | 295.7K | 104.6K (1.5Γ) |
| Favorites | 142.1K | 394.6K | 252.5K (2.8Γ) |
| Rating | 71.0% | 86.2% | β |
| Global rank (players) | #1,444 | #1,526 | of 4,380 |
| Trending score | -4.7 | 57.7 | β |
| Created | Jun 4, 2019 | May 22, 2021 | β |
| Genre | Action | RPG | β |
Other comparisons
[new weapons!] brawl 2 vs Snowcone Stand[new weapons!] brawl 2 vs Warfare Tycoon[new weapons!] brawl 2 vs Charisma Hospital: Medical Simulator[new weapons!] brawl 2 vs [New Update] Beat up simulator[new weapons!] brawl 2 vs [] BUILD your Butterfly Garden[new weapons!] brawl 2 vs Bobruisk RP [BANDITS]Compare two other games β
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history β 4 days for [new weapons!] brawl 2, 4 for [] InVision's: Web-Verse [V3].